Finally, future studies should probe and validate the potential use of the GR—possibly coupled with other cancer-associated steroid hormone nuclear receptors, e.g., androgen receptor (AR; NR3C4) [40,41]—as a prognostic and predictive biomarker in NSCLC. The gene discussed is NR3C1; the disease is cancer.